← Product Code [FGE](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/FGE) · K963691 # COURIER BALLOON DILATATION CATHETER (K963691) _Boston Scientific Corp · FGE · Dec 12, 1996 · Gastroenterology, Urology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/FGE/K963691 ## Device Facts - **Applicant:** Boston Scientific Corp - **Product Code:** [FGE](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/FGE.md) - **Decision Date:** Dec 12, 1996 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 876.5010 - **Device Class:** Class 2 - **Review Panel:** Gastroenterology, Urology - **Attributes:** Therapeutic ## Indications for Use The Courier™ Balloon Dilatation Catheter is indicated for PTA of the iliac, femoral and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. In addition, certain sizes of the Diamond balloon catheter are indicated for stent deployment / optimization of the J&J Palmaz Biliary Stent into the biliary ducts. ## Device Story Over-the-wire balloon dilatation catheter; compatible with guidewires ≤.035". Used by physicians in clinical settings for angioplasty and stent deployment. Device inserted into vasculature/biliary ducts; balloon inflated to dilate stenotic lesions or deploy stents. Provides mechanical force to restore vessel patency; improves blood flow or biliary drainage. ## Clinical Evidence Bench testing only. Functional, integrity, and biocompatibility testing performed per ISO-10993 standards. ## Technological Characteristics Over-the-wire balloon dilatation catheter; compatible with guidewires ≤.035". Biocompatibility per ISO-10993. ## Regulatory Identification A biliary catheter and accessories is a tubular flexible device used for temporary or prolonged drainage of the biliary tract, for splinting of the bile duct during healing, or for preventing stricture of the bile duct. This generic type of device may include a bile collecting bag that is attached to the biliary catheter by a connector and fastened to the patient with a strap. ## Special Controls *Classification.* Class II (special controls). The device, when it is a bile collecting bag or a surgical biliary catheter that does not include a balloon component, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9. ## Predicate Devices - BSC -- PEMT-5 Balloon Dilatation Catheter - BSC -- Courier™ Balloon Catheter ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} K963691 p192 Medi-tech Courier™ Balloon Dilatation Catheter September 12, 1996 # ATTACHMENT H ## SUMMARY OF SAFETY AND EFFECTIVENESS Pursuant to §513(i)(3)(A) of the Food, Drug, and Cosmetic Act, Boston Scientific Corporation is required to submit with this Premarket Notification either an "... adequate summary of any information respecting safety and effectiveness or state that such information will be made available upon request of any person." Boston Scientific Corporation choose to submit a summary of information respecting safety and effectiveness. According to §513(i)(3)(B), "Any summary under subparagraph (A) respecting a device shall contain detailed information regarding data concerning adverse health effects..." The summary regarding the adverse health effects of the proposed Courier™ Balloon Dilatation Catheter is as follows: **Trade Name:** Courier™ Balloon Dilatation Catheter **Manufacturer:** Boston Scientific Corporation One Boston Scientific Place Natick, MA 01760 **Device Generic Name:** Balloon Dilatation Catheter **Classification:** According to Section 13 of the Federal Food, Drug and Cosmetic Act, the device classification is Class II, Performance Standards. ### Predicate Devices: The following devices are referenced in this premarket notification as predicate devices for the Diamond™ Balloon Dilatation Catheter: - BSC -- PEMT-5 Balloon Dilatation Catheter - BSC -- Courier™ Balloon Catheter All of the devices mentioned above have been determined substantially equivalent by FDA. ### Device Description: The proposed Courier™ Balloon Dilatation catheter is an over-the-wire catheter designed to be placed over guidewires which have outer diameters of .035" or smaller. ### Indications for Use: The Courier™ Balloon Dilatation Catheter is indicated for PTA of the iliac, femoral and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. In addition, certain sizes of the Diamond balloon catheter are indicated for stent deployment / optimization of the J&J Palmaz Biliary Stent into the biliary ducts. 000066 {1} K 96 3691 p292 Medi-tech Courier™ Balloon Dilatation Catheter September 12, 1996 ## Safety and Performance: Functional and integrity bench testing and biocompatibility testing (according to the FDA guidance document, ODE Blue Book Memorandum #G95-1, May 1, 1995, Use of International Standard ISO-10993, "Biological Evaluation of Medical Devices Part 1: Evaluation and Testing") were performed, and the data supported the substantial equivalence of the Courier™ Balloon Dilatation Catheter to the PEMT-5 Balloon Dilatation Catheter. ## Conclusion: Based on the Indication for Use, technological characteristics and safety and performance testing, the Courier™ Balloon Dilatation Catheter has been shown to be safe and effective for its intended use. 000067 --- **Source:** [https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/FGE/K963691](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/FGE/K963691) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com